First Financial Corp’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.2K | Hold |
252
| – | – | ﹤0.01% | 259 |
|
|
2026
Q1 | $13.9K | Hold |
252
| – | – | 0.01% | 252 |
|
|
2025
Q4 | $12.4K | Hold |
252
| – | – | ﹤0.01% | 262 |
|
|
2025
Q3 | $10.9K | Hold |
252
| – | – | ﹤0.01% | 264 |
|
|
2025
Q2 | $9.68K | Hold |
252
| – | – | ﹤0.01% | 264 |
|
|
2025
Q1 | $9.76K | Sell |
252
-20
| -7% | -$732 | ﹤0.01% | 290 |
|
|
2024
Q4 | $9.2K | Hold |
272
| – | – | ﹤0.01% | 312 |
|
|
2024
Q3 | $11.1K | Hold |
272
| – | – | 0.01% | 284 |
|
|
2024
Q2 | $10.5K | Hold |
272
| – | – | 0.01% | 297 |
|
|
2024
Q1 | $11.7K | Sell |
272
-20
| -7% | -$825 | 0.01% | 324 |
|
|
2023
Q4 | $10.8K | Hold |
292
| – | – | 0.01% | 310 |
|
|
2023
Q3 | $10.6K | Hold |
292
| – | – | 0.01% | 326 |
|
|
2023
Q2 | $10.4K | Sell |
292
-40
| -12% | -$1.44K | 0.01% | 287 |
|
|
2023
Q1 | $11.8K | Hold |
332
| – | – | 0.01% | 286 |
|
|
2022
Q4 | $11.7K | Hold |
332
| – | – | 0.01% | 289 |
|
|
2022
Q3 | $10K | Sell |
332
-320
| -49% | -$12.1K | 0.01% | 290 |
|
|
2022
Q2 | $36K | Buy |
652
+252
| +63% | +$13.9K | 0.02% | 230 |
|
|
2022
Q1 | $22K | Hold |
400
| – | – | 0.01% | 266 |
|
|
2021
Q4 | $22K | Hold |
400
| – | – | 0.01% | 266 |
|
|
2021
Q3 | $19K | Hold |
400
| – | – | 0.01% | 269 |
|
|
2021
Q2 | $20K | Hold |
400
| – | – | 0.01% | 267 |
|
|
2021
Q1 | $18K | Hold |
400
| – | – | 0.01% | 265 |
|
|
2020
Q4 | $18K | Hold |
400
| – | – | 0.01% | 266 |
|
|
2020
Q3 | $19K | Hold |
400
| – | – | 0.02% | 259 |
|
|
2020
Q2 | $20K | Hold |
400
| – | – | 0.02% | 242 |
|
|
2020
Q1 | $19K | Hold |
400
| – | – | 0.02% | 239 |
|
|
2019
Q4 | $23K | Hold |
400
| – | – | 0.02% | 254 |
|
|
2019
Q3 | $21K | Buy |
+400
| New | +$20.6K | 0.02% | 263 |
|
|
2018
Q3 | – | Sell |
-160
| Closed | -$8K | – | 333 |
|
|
2018
Q2 | $8K | Hold |
160
| – | – | 0.01% | 304 |
|
|
2018
Q1 | $8K | Hold |
160
| – | – | 0.01% | 317 |
|
|
2017
Q4 | $7K | Sell |
160
-53
| -25% | -$2.45K | ﹤0.01% | 336 |
|
|
2017
Q3 | $11K | Hold |
213
| – | – | 0.01% | 336 |
|
|
2017
Q2 | $11K | Hold |
213
| – | – | 0.01% | 345 |
|
|
2017
Q1 | $11K | Buy |
213
+160
| +302% | +$8.12K | 0.01% | 352 |
|
|
2016
Q4 | $3K | Sell |
53
-775
| -94% | -$38.3K | ﹤0.01% | 380 |
|
|
2016
Q3 | $45K | Sell |
828
-320
| -28% | -$17.5K | 0.03% | 231 |
|
|
2016
Q2 | $63K | Sell |
1,148
-444
| -28% | -$23.4K | 0.04% | 223 |
|
|
2016
Q1 | $80K | Hold |
1,592
| – | – | 0.04% | 212 |
|
|
2015
Q4 | $80K | Hold |
1,592
| – | – | 0.04% | 211 |
|
|
2015
Q3 | $77K | Hold |
1,592
| – | – | 0.04% | 217 |
|
|
2015
Q2 | $83K | Hold |
1,592
| – | – | 0.04% | 211 |
|
|
2015
Q1 | $92K | Hold |
1,592
| – | – | 0.05% | 204 |
|
|
2014
Q4 | $85K | Hold |
1,592
| – | – | 0.04% | 218 |
|
|
2014
Q3 | $91K | Hold |
1,592
| – | – | 0.05% | 211 |
|
|
2014
Q2 | $107K | Hold |
1,592
| – | – | 0.05% | 203 |
|
|
2014
Q1 | $107K | Hold |
1,592
| – | – | 0.05% | 199 |
|
|
2013
Q4 | $107K | Buy |
1,592
+160
| +11% | +$10.4K | 0.05% | 198 |
|
|
2013
Q3 | $90K | Hold |
1,432
| – | – | 0.04% | 215 |
|
|
2013
Q2 | $89K | Buy |
+1,432
| New | +$90.9K | 0.04% | 215 |
|
Other funds holding GSK
LMFP
DLA
TNB
AA
SIS
KFP
QCM
TH
GC
BB
First Financial Corp's GSK Position: Q2 2026 in Review
First Financial Corp held its GSK (GSK) position steady in Q2 2026 at 252 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #259.
First Financial Corp first reported a position in GSK in Q2 2013 and has held it in 49 quarters since. The position peaked at $107K in Q2 2014. 216 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- First Financial Corp held 252 shares of GSK worth $13.2K as of Q2 2026.
- First Financial Corp left its GSK share count unchanged in Q2 2026.
- GSK made up ﹤0.01% of First Financial Corp's portfolio in Q2 2026, its #259 holding.
- First Financial Corp first reported a position in GSK in Q2 2013 and has held it in 49 quarters since.
- First Financial Corp's GSK position peaked at $107K in Q2 2014.
- 216 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on First Financial Corp's 13F filing for Q2 2026, filed 7 Jul 2026.